The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.

The Food and Drug Administration (FDA) on Friday announced it had cleared a new test to help diagnose adults with Alzheimer’s ...

The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...

The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...

New data show that lecanemab is well tolerated outside of clinical trial setting, with expected and manageable side effects.

Every year in clinics across the country, thousands of people are asked to draw the face of a clock, repeat lists of words and complete seemingly simple tasks. Many leave with life-changing news: ...

E arly detection is imperative to catch neurodegenerative diseases like dementia in their early stages and slow disease ...

In cross-sectional models, greater sedentary time was tied to a smaller Alzheimer's disease-imaging MRI signature (β = ...

Are you reading this while lounging on your couch? You might want to stand up. New research shows that too much sitting could damage your brain, regardless of your exercise habits.

Lecanemab and donanemab (Kisunla), another anti-amyloid treatment, won approval based on evidence that they slowed cognitive ...

Scientists at the University of Miami have discovered that the lower number in a blood pressure reading—called diastolic ...